Citigroup
TYRA icon

Citigroup’s Tyra Biosciences TYRA Stock Holding History

Citigroup’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$598K Sell
27,349
-34,930
-56% -$960K ﹤0.01% 3654
2026
Q2 		$1.99M Buy
62,279
+56,288
+940% +$1.86M ﹤0.01% 2938
2026
Q1 		$229K Buy
5,991
+2,174
+57% +$70.4K ﹤0.01% 3946
2025
Q4 		$100K Buy
3,817
+2,110
+124% +$38.8K ﹤0.01% 4323
2025
Q3 		$23.9K Sell
1,707
-7,790
-82% -$88.8K ﹤0.01% 4767
2025
Q2 		$90.9K Sell
9,497
-6,010
-39% -$57.1K ﹤0.01% 4452
2025
Q1 		$144K Sell
15,507
-1,296
-8% -$16.8K ﹤0.01% 4387
2024
Q4 		$234K Buy
16,803
+2,136
+15% +$38.8K ﹤0.01% 4326
2024
Q3 		$345K Buy
14,667
+10,234
+231% +$215K ﹤0.01% 3977
2024
Q2 		$70.9K Sell
4,433
-2,673
-38% -$46K ﹤0.01% 4393
2024
Q1 		$117K Buy
7,106
+5,075
+250% +$83.2K ﹤0.01% 4229
2023
Q4 		$28.1K Buy
2,031
+2,012
+10,589% +$26K ﹤0.01% 4847
2023
Q3 		$262 Sell
19
-4,146
-100% -$61.5K ﹤0.01% 5287
2023
Q2 		$70.9K Buy
+4,165
New +$60.4K ﹤0.01% 4423
2023
Q1 		– Sell
-89
Closed -$676 – 5867
2022
Q4 		$676 Sell
89
-111
-56% -$785 ﹤0.01% 5465
2022
Q3 		$2K Sell
200
-734
-79% -$6.71K ﹤0.01% 5540
2022
Q2 		$7K Buy
934
+475
+103% +$3.78K ﹤0.01% 5514
2022
Q1 		$5K Sell
459
-2,706
-85% -$32.1K ﹤0.01% 5841
2021
Q4 		$45K Buy
3,165
+2,725
+619% +$54.1K ﹤0.01% 5122
2021
Q3 		$8K Buy
+440
New +$8.41K ﹤0.01% 5526

Other funds holding TYRA

Canaan Partners XI
Canaan Partners XI Menlo Park, California $66.9M AUM 86.25% 1-Year Est. Return
Oppenheimer & Co
Oppenheimer & Co New York $9.5B AUM 27.65% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Auour Investments
Auour Investments Woburn, Massachusetts $353M AUM 8.66% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Citigroup's TYRA Position: Q3 2026 in Review

Citigroup reduced its Tyra Biosciences (TYRA) stake by 56% in Q3 2026, selling an estimated $960K and leaving 27,349 shares worth $598K. The position accounts for ﹤0.01% of the portfolio, ranked #3654.

Citigroup first reported a position in TYRA in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.99M in Q2 2026. 31 funds tracked by Wall St. Rank hold TYRA as of Q3 2026.

  • Citigroup held 27,349 shares of Tyra Biosciences worth $598K as of Q3 2026.
  • Citigroup sold 34,930 Tyra Biosciences shares in Q3 2026, an estimated $960K.
  • Tyra Biosciences made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3654 holding.
  • Citigroup first reported a position in Tyra Biosciences in Q3 2021 and has held it in 20 quarters since.
  • Citigroup's Tyra Biosciences position peaked at $1.99M in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Tyra Biosciences as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.